IRIS
PANTANO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 674
AS - Asia 406
EU - Europa 348
OC - Oceania 12
SA - Sud America 11
AF - Africa 3
Totale 1.454
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 652
CN - Cina 170
SG - Singapore 151
GB - Regno Unito 118
IT - Italia 95
IN - India 34
DE - Germania 28
NL - Olanda 21
CA - Canada 20
CZ - Repubblica Ceca 19
FR - Francia 14
JP - Giappone 13
TR - Turchia 13
AU - Australia 12
FI - Finlandia 12
AT - Austria 8
BR - Brasile 7
HK - Hong Kong 7
KR - Corea 6
RO - Romania 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
DK - Danimarca 3
ES - Italia 3
GR - Grecia 3
PT - Portogallo 3
ZA - Sudafrica 3
BE - Belgio 2
CL - Cile 2
LV - Lettonia 2
RS - Serbia 2
SE - Svezia 2
AM - Armenia 1
AR - Argentina 1
BY - Bielorussia 1
CH - Svizzera 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
MD - Moldavia 1
MS - Montserrat 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
UA - Ucraina 1
YE - Yemen 1
Totale 1.454
Salva come PNG Salva come JPEG
Città #
Ashburn 202
Boardman 169
Shanghai 113
London 112
Singapore 97
San Francisco 32
Los Angeles 30
Rome 30
Pune 24
Toronto 20
Brno 18
Amsterdam 17
Council Bluffs 17
Redmond 16
Seattle 15
Washington 14
Helsinki 12
Munich 9
Canberra 6
Hong Kong 6
Xi'an 6
Hyderabad 5
Melbourne 5
Naples 5
Paris 5
Yeonsu-gu 5
Brooklyn 4
Padova 4
Riyadh 4
São Paulo 4
Vienna 4
West Jordan 4
Athens 3
Copenhagen 3
Durham 3
Ningbo 3
Oklahoma City 3
Pescara 3
Porto 3
Tokyo 3
Ankara 2
Anyang 2
Beijing 2
Caluire-et-Cuire 2
Charlotte 2
Ferrara di Monte Baldo 2
Genoa 2
Gragnano 2
Haikou 2
Johannesburg 2
Karthaus 2
Kragujevac 2
Lyon 2
Madrid 2
Miami 2
Milan 2
New York 2
Oniferi 2
Prineville 2
Riga 2
Santa Clara 2
Scafati 2
Wuhan 2
Yuncheng 2
Zhengzhou 2
Agordo 1
Amman 1
Bari 1
Berlin 1
Brussels 1
Budapest 1
Cagliari 1
Centurion 1
Changchun 1
Charleston 1
Chisinau 1
Clifton 1
Costabissara 1
Dalsjoefors 1
Dezhou 1
Dorchester 1
Ferrara 1
Forest City 1
Fort Worth 1
Frankfurt am Main 1
Guangzhou 1
Guiyang 1
Haifa 1
Handan 1
Hanover 1
Krasnoyarsk 1
Kunming 1
Kuwait City 1
Lancaster 1
Langfang 1
Lima 1
Lincoln 1
Luzzara 1
Macerata 1
Manassas 1
Totale 1.123
Salva come PNG Salva come JPEG
Nome #
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 39
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 39
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 25
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 20
Anterior and posterior vaginal myomectomy: A new surgical technique 17
Biological effects of cabozantinib on bone microenvironment 17
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 17
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 16
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 16
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 16
Bone Health in Cancer Patients 16
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial 16
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential 16
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 16
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma 16
Premetastatic niche: ready for new therapeutic interventions? 15
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 15
Molecular prognostic factors in patients with pancreatic cancer 15
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 15
Denosumab for cancer-related bone loss 15
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 15
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer 14
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 14
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 14
Integrin alpha-5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions 14
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 14
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 13
New developments of aminobisphosphonates: the double face of Janus 13
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 13
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 13
Role of glyoxalase-1 in trabectedin-resistant myxoid liposarcoma 13
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 13
Natural history of skeletal disease in primary biliary cancers. National survey on behalf of GICO group (Gruppo Italiano Colangiocarcinoma – Onlus) 13
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 12
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 12
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models 12
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 12
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 12
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker? 12
Facing SARS-CoV-2 outbreak in immunotherapy era 12
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 12
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 12
Bone metastases in biliary cancers: A multicenter retrospective survey 11
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients 11
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 11
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey 11
New targets, new drugs for metastatic bone pain: a new philosophy 11
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 11
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma 11
Dicer and Drosha Expression and Response to Bevacizumab-Based Therapy in Advanced Colorectal Cancer Patients 11
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 10
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 10
Interventional radiologist's perspective on the management of bone metastatic disease 10
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 10
Targeting bone metastases starting from the preneoplastic niche: home sweet home 10
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7) 10
Tissue invasion and metastasis: Molecular, biological and clinical perspectives. 10
Deregulation of dicer and mir-155 expression in liposarcoma 10
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 10
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 10
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 10
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 10
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis 10
CETUXIMAB: From bench to bedside 10
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 10
M1-polarized macrophages as predictor of poor response to trabectedin treatment in myxoid liposarcoma 10
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms 10
Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors 10
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 9
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 9
Current and Emerging Biomarkers Predicting Bone Metastasis Development 9
Dynamic changes of receptor activator of nuclear factor-κB expression in circulating tumor cells during denosumab predict treatment effectiveness in metastatic breast cancer 9
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence 9
The role of bone microenvironment, vitamin D and calcium 9
Bone-Targeted Agents 9
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 9
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 9
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey 9
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives 9
Effect of cholesterol and triglyceride increases on time to progression in renal clear cell cancer patients treated with everolimus 9
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 9
Designing a broad-spectrum integrative approach for cancer prevention and treatment 9
Osteoporosis 2014 9
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 9
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature 8
Magnesium: are we better off without it? 8
Determinants of bone specific metastasis in prostate cancer 8
Response to cabozantinib in renal cell carcinoma with cardiac metastases 8
Emerging Therapeutic Targets in Osteoncology 8
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 8
Novel Biomarkers predicting the development of bone metastasis in Early Breast Cancer 8
TUMORI NEUROENDOCRINI 8
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients 8
New molecular targets in bone metastases 8
Natural history of malignant bone disease in gastric cancer: Final results of a multicenter bone metastasis survey 8
Targeting bone metastases: New drugs for new targets 8
Natural history of malignant bone disease in non-small cell lung cancer: Preliminary results of a multicenter bone metastasis survey 8
miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes 8
Prognostic and predictive factors in pancreatic cancer 8
Effects of cabozantinib on bone turnover markers in patients with metastatic renal cell carcinoma 8
Totale 1.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.554
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 9 1 89 4 8 1 12 1 3 200
2022/202363 2 1 0 1 4 3 7 15 1 3 23 3
2023/2024508 16 49 30 31 50 224 6 20 6 24 16 36
2024/2025665 76 92 206 49 39 137 66 0 0 0 0 0
Totale 1.564